T. Rowe Price Associates’s Tenax Therapeutics TENX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.2M Buy
2024
Q4
Sell
2024
Q3
$84K Buy